Trends in gynecologic cancer among elderly women in Denmark, 1980-2012

Acta Oncologica
Anja Ør KnudsenAcademy of Geriatric Cancer Research (AgeCare)

Abstract

The aim of this analysis was to describe trends in incidence, mortality, prevalence, and survival in Danish women with gynecologic cancer from 1980-2012 comparing women aged 70 years or more with younger women. Gynecologic cancers included were ICD-10 codes C53 (cancer of the cervix uteri), C54 (corpus uteri cancer), C56 (ovarian cancer) and C57 (Fallopian tube cancer). Data derived from the NORDCAN database with comparable data on cancer incidence, mortality, prevalence and relative survival in the Nordic countries, where the Danish data are delivered from the Danish Cancer Registry and the Danish Cause of Death Registry with follow-up for death or emigration until the end of 2013. For cervical cancer the incidence decreased among women aged less than 70 years and remained stable among the elderly. The mortality rates were clearly separated by age groups with a 2-3 fold higher mortality rate among 70 + years-old than younger women. The mortality rates, however, decreased in all age groups from 1980-2012. For ovarian and Fallopian tube cancers the incidence was almost constant, whereas the average annual number of deaths decreased over time from 466 in 1980 to 396 in 2012. The mortality rates were clearly separated by age group...Continue Reading

References

Nov 15, 1988·International Journal of Cancer. Journal International Du Cancer·M Ewertz, S K Kjaer
Jul 12, 2002·Clinical Oncology : a Journal of the Royal College of Radiologists·H LukkaUNKNOWN Cancer Care Ontario Practice Guidelines Initiative Gynecology Disease Site Group
Sep 4, 2003·Journal of the National Cancer Institute·Andreas du BoisUNKNOWN Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group
Dec 26, 2003·Statistics in Medicine·Paul W DickmanTimo Hakulinen
Mar 9, 2006·Acta Obstetricia Et Gynecologica Scandinavica·Marianne KyndiSusanne Krüger Kjaer
Nov 22, 2007·Gynecologic Oncology·Cyllene R MorrisRosemary D Cress
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bradley J MonkDavid Cella
May 2, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kevin S Scher, Arti Hurria
Dec 10, 2013·Gynecologic Oncology·Usha MenonAleksandra Gentry-Maharaj
Feb 21, 2014·The New England Journal of Medicine·Krishnansu S TewariBradley J Monk
Sep 19, 2014·World Journal of Gastrointestinal Oncology·Víctor M Castellano-MegíasFrancisco Colina-Ruizdelgado
Jan 15, 2015·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Britton TrabertLouise A Brinton
Mar 27, 2015·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Shinsuke HanawaMakio Shozu

❮ Previous
Next ❯

Citations

Dec 15, 2017·Journal of Cancer Research and Therapeutics·Song-Ping LiuKe-Qin Hua
Jul 14, 2017·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Lital Keinan-BokerCatherine Hayes
Jul 20, 2020·International Journal of Cancer. Journal International Du Cancer·Line W GustafsonAnne Hammer
Nov 18, 2021·Journal of Surgical Oncology·Sabrina PiedimonteLiat Hogen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Acta Oncologica
Jeanette D JensenAcademy of Geriatric Cancer Research (AgeCare)
Acta Oncologica
Katrine R SchønnemannAcademy of Geriatric Cancer Research (AgeCare)
Acta Oncologica
Charlotte KristiansenAcademy of Geriatric Cancer Research (AgeCare)
Acta Oncologica
Mads Hvid PoulsenAcademy of Geriatric Cancer Research (AgeCare)
Acta Oncologica
M EwertzAcademy of Geriatric Cancer Research (AgeCare)
© 2022 Meta ULC. All rights reserved